Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and… Read more
Eastwood Bio-Medical Canada Inc (EWOOF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of July 2024: 0.015x
Based on the latest financial reports, Eastwood Bio-Medical Canada Inc (EWOOF) has a cash flow conversion efficiency ratio of 0.015x as of July 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.58K) by net assets ($-1.14 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Eastwood Bio-Medical Canada Inc - Cash Flow Conversion Efficiency Trend (2013–2023)
This chart illustrates how Eastwood Bio-Medical Canada Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Eastwood Bio-Medical Canada Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eastwood Bio-Medical Canada Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vext Science Inc
OTCQX:VEXTF
|
0.018x |
|
PPK Group Limited
PINK:PLPKF
|
-0.034x |
|
Alaska Energy Metals Corporation
OTCQB:AKEMF
|
0.009x |
|
Adaptimmune Therapeutics Plc
NASDAQ:ADAP
|
0.490x |
|
In The F
KO:014990
|
0.082x |
|
Resilient Property Income Fund Ltd
JSE:RES
|
0.031x |
|
FreeMs Corporation
KQ:053160
|
0.004x |
|
Alan Allman Associates SA
PA:AAA
|
0.275x |
Annual Cash Flow Conversion Efficiency for Eastwood Bio-Medical Canada Inc (2013–2023)
The table below shows the annual cash flow conversion efficiency of Eastwood Bio-Medical Canada Inc from 2013 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-10-31 | $-840.80K | $-12.17K | 0.014x | -0.85% |
| 2022-10-31 | $-215.88K | $-3.15K | 0.015x | -98.19% |
| 2021-10-31 | $-116.48K | $-93.80K | 0.805x | +168.15% |
| 2020-10-31 | $344.45K | $-407.01K | -1.182x | -770.13% |
| 2019-10-31 | $997.99K | $-135.53K | -0.136x | +43.59% |
| 2018-10-31 | $1.89 Million | $-454.79K | -0.241x | -87.18% |
| 2017-10-31 | $2.76 Million | $-355.28K | -0.129x | -34.57% |
| 2016-10-31 | $3.21 Million | $-306.58K | -0.096x | -31.67% |
| 2015-10-31 | $3.73 Million | $-270.51K | -0.073x | -118.34% |
| 2014-10-31 | $3.54 Million | $1.40 Million | 0.396x | +187.58% |
| 2013-10-31 | $-199.41K | $90.12K | -0.452x | -- |